|
AstraZeneca's Kid Asthma Drug Patent Deemed Obvious
Law360 (subscription) Law360, Los Angeles (February 13, 2015, 4:49 PM ET) — A New Jersey federal judge on Friday opened the door for Sandoz Inc., Apotex Inc. and other competitors of AstraZeneca PLC to launch generic versions of its pediatric asthma medication, finding … |
View full post on asthma – Google News